Plain-English translation of NCT06718842 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a daily walking program can help improve liver health in children with phenylketonuria (PKU) who also have fatty liver disease. Half of the children in the study will follow a supervised walking program done online every day for eight weeks, while the other half will wait to see if the walking program helps.
Children with PKU often develop fatty liver disease, which can harm their health. Doctors want to know if a simple, safe activity like daily walking can help reduce liver damage in this group without requiring medication.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly placed into one of two groups. If you are in the walking group, you will participate in free, online-supervised walking every day for eight weeks—a trained instructor will guide you remotely. If you are in the waiting group, you will not do the walking program during the study, but may be offered it later. The study will check your liver health before and after the eight weeks to see if walking made a difference.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Egypt
Cairo University
Enrollment target
~40 participants
Started
September 2024
Primary completion
January 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
9 Years – 12 Years
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ali Isamil, Lecturer
Cairo University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.